Some experts believe race-day meds are a drag on U.S. horse racing

06/13/2011 | New York Times (tiered subscription model), The

The U.S. thoroughbred horse racing industry is experiencing a malaise, with betting amounts, purses and the number of races run all having slipped downward between 2007 and 2010. Some participants in the recent International Summit on Race Day Medication in New York attributed this decline in the public's interest in horse racing in large measure to the use of performance-enhancing drugs in racehorses.

View Full Article in:

New York Times (tiered subscription model), The

Published in Brief:

SmartBrief Job Listings for Health Care

Job Title Company Location
Director, Payer Marketing
Avalere Health
Washington, DC
Consumer Directed Health Plan (CDH) Product Offering Manager
Blue Cross Blue Shield MA
Quincy, MA
Chief Medical Officer, Texas Children's Health Plan
Cejka Executive Search for Texas Childre's Health Plan
Houston, TX
Actuary
Meridian Health Plan
Detroit, MI
Chief Financial Officer
B. E. Smith
Miramar, FL